Sepsis News and Research

Latest Sepsis News and Research

Researchers reveal obesity paradox among older Americans suffering from sepsis

University of Michigan Health System researchers revealed an obesity paradox among older Americans suffering from sepsis.

6 Aug 2014

Emergency department closures can affect death rates, finds UCSF research

In the first analysis of its kind, UC San Francisco research shows that emergency department closures can have a ripple effect on patient outcomes at nearby hospitals.

5 Aug 2014

Astute Medical, OCD partner to expand access to new acute kidney injury test

Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury (AKI), a prevalent and deadly condition.

From Ortho-Clinical Diagnostics, Inc. 28 Jul 2014

Brain network measures placebo effects in Parkinson's disease patients

Investigators at The Feinstein Institute for Medical Research have utilized a new image-based strategy to identify and measure placebo effects in randomized clinical trials for brain disorders. The findings are published in the August issue of The Journal of Clinical Investigation.

19 Jul 2014

First publication describing use of CytoSorb during cardiac surgery

CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber in multiple countries worldwide, announced the PDF availability of the first publication describing the use of CytoSorb® intra-operatively during cardiac surgery at the Ludwig Maximilian University of Munich Hospital - Grosshadern Campus, in Germany.

17 Jul 2014

Researchers release evidence substantiating unexpected dual role of immune system

University of Leicester researchers have released evidence substantiating an unexpected dual role of an important component of the immune system.

17 Jul 2014

'Pure mass of HES molecules' explains toxicity to renal tubule cells

The increased risk of kidney injury related to the use of hydroxyethyl starch (HES) in resuscitation fluids reflects the mass of HES molecules, according to a report in Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

14 Jul 2014

Study: Minimally invasive aortic repair procedure safer for patients

Researchers at the University of California, San Diego School of Medicine have documented the safety benefits of aortic stent grafts inserted during minimally invasive surgery to repair abdominal aortic aneurysms - weaknesses in the body's largest artery that can rupture, causing potentially lethal internal bleeding.

10 Jul 2014

Keck Medicine of USC study identifies potential therapeutic target for inflammation

Molecular microbiologists from the Keck School of Medicine of the University of Southern California have discovered that mice lacking a specific component of the immune system are completely resistant to sepsis, a potentially fatal complication of infection.

10 Jul 2014

Scientists uncover mechanisms that can protect against lethal bacteria

An important development in understanding how the bacterium that causes pneumonia, meningitis and septicaemia remains harmlessly in the nose and throat has been discovered at the University of Liverpool's Institute of Infection and Global Health.

8 Jul 2014

Researcher describes possible implications of increased gravity effect on immunity

Before you swat away the next fruit fly, consider instead just how similar its biological complexities are to our own.

4 Jul 2014

Clinicians need to be sensitive to women's reproductive health needs in times of conflict

Clinicians need to be sensitive and aware of the unique challenges of women's reproductive health needs in times of conflict, suggests a new review published today (4 July) in The Obstetrician & Gynaecologist.

4 Jul 2014

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, a global biopharmaceutical leader, and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia (certolizumab pegol) in dermatology.

3 Jul 2014

New technology could revolutionize treatment and prevention of sepsis

The National Science Foundation has just awarded $200,000 to engineers at Oregon State University who have developed a new technology that they believe could revolutionize the treatment and prevention of sepsis.

27 Jun 2014

Adding MM-398 to standard treatment improves survival in metastatic pancreatic cancer patients

Adding the novel MM-398 to standard treatment for metastatic pancreatic cancer patients who have already received gemcitabine improves survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona.

26 Jun 2014

St. Mary's Medical Center honored with Healthgrades 2014 Women's Health Excellence Award

Dignity Health St. Mary's Medical Center has received the 2014 Women's Health Excellence Award from Healthgrades, the leading online resource for comprehensive information about physicians and hospitals.

25 Jun 2014

First Edition: June 12, 2014

Today's headlines include stories examining how Eric Cantor's primary defeat will change the House GOP leadership and the Republican strategy to replace the health law.

12 Jun 2014

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

Boehringer Ingelheim today announced that new data will be presented from 7 abstracts for Gilotrif (afatinib) and investigational compounds, including nintedanib and BI 836845, from its oncology pipeline at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, on May 30 – June 3, 2014.

31 May 2014

Study reveals how BTK mutation triggers drug resistance in CLL patients

A multi-institutional team of researchers has pinpointed exactly what goes wrong when chronic lymphocytic leukemia (CLL) patients develop resistance to ibrutinib, a highly effective, precisely targeted anti-cancer drug.

29 May 2014

Sanofi presents Phase II trial results for investigational vaccine for prevention of CDI

Sanofi Pasteur, the vaccines division of Sanofi, presented Phase II (H-030-012) trial results for an investigational vaccine for the prevention of Clostridium difficile infection at the 114th General Meeting of the American Society for Microbiology.

20 May 2014

Sepsis News and Research

Latest Sepsis News and Research

Researchers reveal obesity paradox among older Americans suffering from sepsis

Emergency department closures can affect death rates, finds UCSF research

Astute Medical, OCD partner to expand access to new acute kidney injury test

Brain network measures placebo effects in Parkinson's disease patients

First publication describing use of CytoSorb during cardiac surgery

Researchers release evidence substantiating unexpected dual role of immune system

'Pure mass of HES molecules' explains toxicity to renal tubule cells

Study: Minimally invasive aortic repair procedure safer for patients

Keck Medicine of USC study identifies potential therapeutic target for inflammation

Scientists uncover mechanisms that can protect against lethal bacteria

Researcher describes possible implications of increased gravity effect on immunity

Clinicians need to be sensitive to women's reproductive health needs in times of conflict

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

New technology could revolutionize treatment and prevention of sepsis

Adding MM-398 to standard treatment improves survival in metastatic pancreatic cancer patients

St. Mary's Medical Center honored with Healthgrades 2014 Women's Health Excellence Award

First Edition: June 12, 2014

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

Study reveals how BTK mutation triggers drug resistance in CLL patients

Sanofi presents Phase II trial results for investigational vaccine for prevention of CDI

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Sepsis News and Research

Latest Sepsis News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in